big volume, 200 trades today, page-5

This is under the radar big time ... but a couple of institutions are building positions.

Huntley's put out a report with a $1.50 valuation the other day based on very conservative figures, add that that to the recent newspaper article and the word is starting to get out..

They are now signing deals like SSL and Elanco and then throw in Vivagel as a stand alone product (note the global market for an effective gel is $1.5 Bill - Vivagel protects against HIV and Herpes). They will dominate the market.... There is no way I am selling this now.
I honestly believe this stock will be along the lines of CSL and COH in a couple of years...